<DOC>
	<DOCNO>NCT02268149</DOCNO>
	<brief_summary>Study evaluate effect multiple dos BIIL 284 BS pharmacokinetics single dose prednisone</brief_summary>
	<brief_title>Study Evaluate Effect Multiple Doses BIIL 284 BS Pharmacokinetics Prednisone Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Prednisone</mesh_term>
	<criteria>Written inform consent sign date prior participation study All participant study healthy male , age 1850 year old inclusive All participant within ( + 20 % ) ideal body weight ( BrocaIndex ) Nonsmokers ( subject never smoke ) exsmoker least one year smoking history , great five packyears ( 1 pack year = 20 cigarette per day 1 year ) Ability comply concomitant therapy restriction detail Clinical Trial Protocol ( CTP ) Subjects prescription drug . O.T.C . drug must discontinue least two week prior participation study . If throughout study , subject need O.T.C . medication , investigator call clinical monitor review casebycase basis . Restrictions different medication describe CTP Subjects evidence clinically relevant concomitant disease base upon complete medical history , full physical examination , chestxray ( do previous 6 month ) , ECG clinical laboratory test Viral respiratory tract infection respiratory tract infection within six week precede dose study medication Small difficult locate arm hand vein would impair clinician ability draw blood sample place venous catheter Subjects know drug alcohol dependence ( absence dependency 10 year ) drink 60 g alcohol per day , history significant allergic reaction drug sensitivity aspirin positive drug screen Use investigational new drug precede month six halflives ( whichever great ) prior first screen Visit 1 Donation blood month precede Visit 1 Subjects receive hyposensitization therapy stable dose last three month Visit 1 Subjects know gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Subjects diseases central nervous system ( epilepsy ) psychiatric disorder Subjects known history orthostatic hypotension , faint spell blackouts Subjects chronic relevant acute infection Subjects history allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Subjects eosinophilia &gt; 7 % Subjects receive drug , might influence result trial week prior dose study medication Subjects participate excessive physical activity ( e.g . competitive sport ) within last week dose study medication</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>